Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4857)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2021 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang H, Li W. Recent update on comprehensive therapy for advanced hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(8): 845-855 [PMID: 34457190 DOI: 10.4251/wjgo.v13.i8.845] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/845.htm |
| Number | Citing Articles |
| 1 |
Manuela Cabiati, Melania Gaggini, Paolo De Simone, Costanza Salvadori, Serena Del Turco, Chiara Caselli, Antonella Cecchettini, Silvia Del Ry. Expression profile of adrenomedullin and its specific receptors in liver tissues from patients with hepatocellular carcinoma and in tumorigenic cell line-secreted extracellular vesicles. Pathology - Research and Practice 2023; 243: 154383 doi: 10.1016/j.prp.2023.154383
|
| 2 |
Sung Hoon Choi, Do Young Kim. Regulation of Tumor Microenvironment through YAP/TAZ under Tumor Hypoxia. Cancers 2024; 16(17): 3030 doi: 10.3390/cancers16173030
|
| 3 |
Yinghui Zhu, Dezhi Shan, Lianyi Guo, Shujia Chen, Xiaofei Li. Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma. International Journal of General Medicine 2022; : 1919 doi: 10.2147/IJGM.S343350
|
| 4 |
Tingting Fan, Shijie Li, Kai Li, Jingxu Xu, Sheng Zhao, Jinping Li, Xinglu Zhou, Huijie Jiang. A Potential Prognostic Marker for Recognizing VEGF-Positive Hepatocellular Carcinoma Based on Magnetic Resonance Radiomics Signature. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.857715
|
| 5 |
Songsong Pan, Jiaxi Zheng, Changsheng Shi. Analysis and prediction of the efficacy and influencing factors of camrelizumab combined with TACE and sorafenib in the treatment of advanced hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2023; 149(13): 12479 doi: 10.1007/s00432-023-05050-0
|
| 6 |
Julian L. Goggi, Boominathan Ramasamy, Yun Xuan Tan, Siddesh V. Hartimath, Jun Rong Tang, Peter Cheng, Rasha Msallam, Ann-Marie Chacko, You Yi Hwang, Edward G. Robins, Alexei Bogdanov. Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma. Molecular Imaging 2021; 2021 doi: 10.1155/2021/9305277
|
| 7 |
Claudio Pusceddu, Luigi Mascia, Chiara Ninniri, Nicola Ballicu, Stefano Zedda, Luca Melis, Giulia Deiana, Alberto Porcu, Alessandro Fancellu. The Increasing Role of CT-Guided Cryoablation for the Treatment of Liver Cancer: A Single-Center Report. Cancers 2022; 14(12): 3018 doi: 10.3390/cancers14123018
|
| 8 |
Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil. Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques. Cureus 2024; doi: 10.7759/cureus.72239
|
| 9 |
Yuxin Duan, Hua Zhang, Tao Tan, Wentao Ye, Kunli Yin, Yanxi Yu, Meiqing Kang, Jian Yang, Rui Liao. The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy. BioScience Trends 2023; 17(6): 427 doi: 10.5582/bst.2023.01275
|
| 10 |
Da Mao, Meihong Xu, Qiyu Jiang, Huiwei Sun, Fang Sun, Ruichuang Yang, Yantao Chai, Xiaojuan Li, Boan Li, Yong Li. A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.951831
|
| 11 |
Wen-jun Pei, Hao Zhou, Ying Zeng, Qi-lin Ji, Jing-jing Zhang, Xiu Wang. 3-Bromopyruvate modified with cholesterol enhances anti-hepatoma activity by inducing ferroptosis and apoptosis. Journal of Drug Delivery Science and Technology 2024; : 106426 doi: 10.1016/j.jddst.2024.106426
|
| 12 |
Nan Zhang, Shuiwen Ye, Xinlu Wang, Kang Wang, Fangmin Zhong, Fangyi Yao, Jing Liu, Bo Huang, Feng Xu, Xiaozhong Wang. Hepatic Symbiotic Bacterium L. reuteri FLRE5K1 Inhibits the Development and Progression of Hepatocellular Carcinoma via Activating the IFN-γ/CXCL10/CXCR3 Pathway. Probiotics and Antimicrobial Proteins 2024; 16(4): 1158 doi: 10.1007/s12602-023-10098-y
|
| 13 |
Zhongchao Li, Jingtao Zhong, Chengsheng Zhang, Bo Zhang, Xuetao Shi, Lei Li. Analysis of efficacy and safety for the combination of regorafenib and PD-1 inhibitor in advanced hepatocellular carcinoma: A real-world clinical study. iLIVER 2024; 3(2): 100092 doi: 10.1016/j.iliver.2024.100092
|